Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial

Background: Carious primary molars, symptomless, or with reversible pulpitis are most frequently treated with pulpotomy to maintain arch integrity, otherwise they would be extracted. The present study was conducted to assess clinically and radiographically the success rate of three capping materials...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Randa Youssef Abd Al Gawad, Rasha Mohamed Hatem Hanafy
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
MTA
R
Acceso en línea:https://doaj.org/article/f11ef28fbc9448af87fa4a1bb03a1944
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f11ef28fbc9448af87fa4a1bb03a1944
record_format dspace
spelling oai:doaj.org-article:f11ef28fbc9448af87fa4a1bb03a19442021-11-10T04:19:29ZSuccess rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial1013-905210.1016/j.sdentj.2020.08.007https://doaj.org/article/f11ef28fbc9448af87fa4a1bb03a19442021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1013905220307665https://doaj.org/toc/1013-9052Background: Carious primary molars, symptomless, or with reversible pulpitis are most frequently treated with pulpotomy to maintain arch integrity, otherwise they would be extracted. The present study was conducted to assess clinically and radiographically the success rate of three capping materials: Nanohydroxyapatite (NHA), Mineral Trioxide Aggregate (MTA), and Formocresol (FC) in pulpotomy of primary molars. Methods: A clinical trial was carried out on healthy, four to eight years old children, with 72- second primary molars indicated for pulpotomy. Molars were divided into 3 equal groups (24 teeth each) designated to NHA (group 1), MTA (group 2), and FC (group 3) as pulp medicaments. Treated teeth were finally restored with stainless steel crowns. Subjects were monitored clinically and radiographically after three, six, and twelve months. Statistical analysis was presented as intended to treat analysis. Categorical data were analyzed using Fisher’s exact test. The significance level was set at p ≤ 0.05. Statistical analysis was performed using SPSS, version 26. Results: By the end of the twelve months, the number and percentages of successfully treated molars for Group (1), Group (2) and Group (3) were 10 (41.7%), 19 (79.2%) and 18 (75.0%) respectively; with (NHA) group showing a significantly lower rate of success, (p = 0.019). Conclusions: MTA is still the material of choice for pulpotomy in primary molars. Trial Registration: This trial was registered on Clincal.Trial.gov (https://clinicaltrials.gov), on February 8, 2019 (Retrospectively registered). The protocol ID is 181053. The Identifier is NCT03833557.Randa Youssef Abd Al GawadRasha Mohamed Hatem HanafyElsevierarticleFORMOCRESOLPulpotomyMTANanohydroxyapatiteMedicineRDentistryRK1-715ENSaudi Dental Journal, Vol 33, Iss 7, Pp 560-567 (2021)
institution DOAJ
collection DOAJ
language EN
topic FORMOCRESOL
Pulpotomy
MTA
Nanohydroxyapatite
Medicine
R
Dentistry
RK1-715
spellingShingle FORMOCRESOL
Pulpotomy
MTA
Nanohydroxyapatite
Medicine
R
Dentistry
RK1-715
Randa Youssef Abd Al Gawad
Rasha Mohamed Hatem Hanafy
Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
description Background: Carious primary molars, symptomless, or with reversible pulpitis are most frequently treated with pulpotomy to maintain arch integrity, otherwise they would be extracted. The present study was conducted to assess clinically and radiographically the success rate of three capping materials: Nanohydroxyapatite (NHA), Mineral Trioxide Aggregate (MTA), and Formocresol (FC) in pulpotomy of primary molars. Methods: A clinical trial was carried out on healthy, four to eight years old children, with 72- second primary molars indicated for pulpotomy. Molars were divided into 3 equal groups (24 teeth each) designated to NHA (group 1), MTA (group 2), and FC (group 3) as pulp medicaments. Treated teeth were finally restored with stainless steel crowns. Subjects were monitored clinically and radiographically after three, six, and twelve months. Statistical analysis was presented as intended to treat analysis. Categorical data were analyzed using Fisher’s exact test. The significance level was set at p ≤ 0.05. Statistical analysis was performed using SPSS, version 26. Results: By the end of the twelve months, the number and percentages of successfully treated molars for Group (1), Group (2) and Group (3) were 10 (41.7%), 19 (79.2%) and 18 (75.0%) respectively; with (NHA) group showing a significantly lower rate of success, (p = 0.019). Conclusions: MTA is still the material of choice for pulpotomy in primary molars. Trial Registration: This trial was registered on Clincal.Trial.gov (https://clinicaltrials.gov), on February 8, 2019 (Retrospectively registered). The protocol ID is 181053. The Identifier is NCT03833557.
format article
author Randa Youssef Abd Al Gawad
Rasha Mohamed Hatem Hanafy
author_facet Randa Youssef Abd Al Gawad
Rasha Mohamed Hatem Hanafy
author_sort Randa Youssef Abd Al Gawad
title Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
title_short Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
title_full Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
title_fullStr Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
title_full_unstemmed Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial
title_sort success rate of three capping materials used in pulpotomy of primary molars: a randomized clinical trial
publisher Elsevier
publishDate 2021
url https://doaj.org/article/f11ef28fbc9448af87fa4a1bb03a1944
work_keys_str_mv AT randayoussefabdalgawad successrateofthreecappingmaterialsusedinpulpotomyofprimarymolarsarandomizedclinicaltrial
AT rashamohamedhatemhanafy successrateofthreecappingmaterialsusedinpulpotomyofprimarymolarsarandomizedclinicaltrial
_version_ 1718440708103208960